Vietnam’s pharmaceutical market grew rapidly in the last ten years. Despite some bureaucratic restrictions Vietnam offers great opportunity for suppliers looking to break into this market of close to 100 million people.

In 2018 Vietnam’s healthcare market’s value reached an estimated USD18 billion, with a per-capita expenditure that is expected to double in the next few years.

Vietnam’s pharmaceutical market turnover in 2019 was well above USD6 billion making it the second largest in South East Asia.

Local drug manufacturers are currently meeting about half of the market demand with imports filling in the second 50%.

Pharma14 is happy to announce Vietnam medicine data and tender pricing as the latest additions to our platform.

Sample Vietnam data: Trastuzumab. Ex-factory tender pricing.